Skip to main content
AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)
Loading prices

Policy Tracker

Full Bill Tracker

Every tracked proposal: pending, failed, superseded, stalled and enacted — across psychedelics, cannabis, kratom and 7-OH.

Netherlands

Bills tracked for this country and its states or regions.

2 of 2 tracked bills · newest recorded action first

  • Kamerstuk 24 077, nr. 567

    Motion on a pilot of MDMA-assisted therapy for people with severe PTSD [Motie van de leden Mutluer en Sneller over een pilot met MDMA-ondersteunde therapie voor mensen met ernstige PTSS] (2025-2026)

    1. IntroducedApr 21, 2026 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    No dated action recorded

    The motion asks the government to start an MDMA-therapy pilot under strict medical conditions; no vote result was confirmed in the official record.

    Bill source (opens in a new tab)
  • Staatsblad 2008, 486

    Decree amending Opium Act Lists I and II, adding hallucinogenic mushrooms to List II [Besluit ... plaatsing op lijst II van hallucinogene paddenstoelen] (2008)

    1. IntroducedDate TBC (done)
    2. PassedDate TBC (done)
    3. SignedNov 17, 2008 (done)
    4. Law in effectDec 1, 2008 (done)

    No dated action recorded

    The decree added mushrooms naturally containing psilocin or psilocybin to List II, effective 1 December 2008.

    Bill source (opens in a new tab)